Eloxatin
Drug timelines are a Plus or Pro feature.
220 regulatory and trial events tracked for Eloxatin, covering 2007-11-14 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 2]